Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs) [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of imiquimod cream for actinic keratoses completed. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imiquimod Cream (Aldara) (Imiquimod)

Snippet

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED | Results posted: 2010-06-22